NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Alectinib (Alecensa) is the correct answer. It is an ALK inhibitor used in the treatment of certain cancers, such as non-small cell lung cancer. ALK inhibitors target and inhibit the abnormal ALK gene, which plays a role in the growth and spread of cancer cells in specific types of cancer. Among the other options: - Vemurafenib (Zelboraf) is a BRAF inhibitor used for the treatment of melanoma. - Cobimetinib (Cotellic) is a MEK inhibitor used in combination with other medications for the treatment of melanoma and certain types of colorectal cancer. - Erlotinib (Tarceva) is an EGFR inhibitor used in the treatment of non-small cell lung cancer and pancreatic cancer.